Breakthrough Properties’ Post

Technology’s potential can be overwhelming, but it works wonders when applied strategically within a pharmaceutical company. Chief Digital Officer Christian Born Djurhuus optimized technology for corporate strategy and development groups— taking company performance further. Prism.bio shares Christian’s vision, which is why we create innovative solutions that seamlessly work with a company’s resources and strategy. #pharma #datascience #drugdevelopment

This is fantasting news for the German pharma and biotech landscape: Corporate powerhouses like Daiichi Sankyo US, Eli Lilly and Company and now, most recently, Sanofi are investing heavily in Germany, and thus strengthening Germany as a top-tier rated pharmaceutical location worldwide 💊 🌍 https://lnkd.in/euSGPr_D Let us know what you think - and if you’d like to talk to us at Taylor Wessing about any of this, we would be curious to hear your view & thougths. #TaylorWessing #Biotech #VentureCapital

It was a great day for our whole team and TNO, we launched our spin-off Peregrion. Via this spin-off we want to enrich the partnerships within the Pharmaceutical and Biotech Industry. TNO will further enable us to contribute and take the lead in the paradigm change on generating human #ADME data via the microtracer AMS technology.  #TNO #Pharma #Biotech #DrugDevelopment #Innovation #Valorisation #Pharmacokinetics #DrugMetabolism

A great move for Franz Ziel and Körber - combining forces and strengthening the bond between two partners. It was a pleasure working with the awesome collegues at Franz Ziel, Körber Business Area Pharma and of course the Körber Group Team as well as our external advisors. #wearekörber #strongertogether #manda #pharma #franzziel #protectinglifewithtechnology

nanoencapsulation at reliable quality - prerequisite for easy scale up and for GMP production

We were pleased that Fierce Pharma was inspired by some of the data in our World Preview report. The World Preview features a list of the ten highest-value R&D projects in #pharma, and the team at Fierce has dug into those projects in more detail. Read the full article: https://lnkd.in/ehY-4cVR 📣 Want access to the entire World Preview report? Catch it here: https://lnkd.in/eEVe8Hu4

Maximising the benefits of Digitalisation and Artificial Intelligence for the Pharmaceutical sector is essential for businesses. That’s why PMTC Knowledge Day is bringing together leading experts in industry and academia to discuss how pharma is incorporating these advances into its operations. Dr Ian Jones, founder and CEO of InnoGlobal will speak about shaping the future of global (bio) pharma manufacturing through a 5.0 lens and and how organisations are best positioned to thrive in this space. Register now at https://lnkd.in/evNxMriw #Digitalisation #PMTCKnowledgeDay

We’re back with another episode of Scimplify’s webinar series #MoleculeMakers – Innovating for a Sustainable Future. 🌿 Dive into this session with our esteemed guest Prof Javed Iqbal – Ex-Director, Dr. Reddy's Institute of Life Sciences, and our host Karthik Kumar – Head of the Pharmaceutical Division at Scimplify to explore the critical roles that CDMOs like Scimplify play in pharmaceutical industry. 🔊   The episode titled 𝐌𝐚𝐱𝐢𝐦𝐢𝐳𝐢𝐧𝐠 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐯𝐢𝐭𝐲 & 𝐒𝐜𝐚𝐥𝐚𝐛𝐢𝐥𝐢𝐭𝐲 – 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐨𝐫 𝐂𝐃𝐌𝐎𝐬 will drive discussions on innovative strategies for enhancing scalability and productivity to navigate the challenges and opportunities in the ever-evolving #Pharmaceutical landscape. 💊 👉 Reserve your spot: https://shorturl.at/dKDJ3 📆 9th August, 2024 ⏰ 4:00 PM - 5:00 PM Looking forward to your participation in what promises to be an enlightening discussion. Sounds exciting? Reserve your spot now! 🔺 . . . #CDMO #PharmaceuticalManufacturing #PharmaceuticalIndustry #StrategicInsights #SpecialtyChemicals #WebinarSeries

📌Unlocking the Potential of India's CDMO Sector: A Game-Changer for Pharma Innovation. India's CDMO sector is experiencing a surge in growth, driven by significant investments and a commitment to innovation. This dynamic landscape presents a unique opportunity for pharmaceutical companies seeking to accelerate their drug discovery and development timelines. Learn how this evolution is shaping the future of pharma from Bioprocess Insider. This insightful article explores the key trends and challenges facing the industry, highlighting the critical role of CDMOs in delivering faster, more cost-effective solutions. To read the full article, visit the link in comments section 🔗 #CDMO #IndiaPharma #Bioprocessing #Innovation #Biotech #Pharma #DrugDiscovery #DrugDevelopment

Our portfolio company, Biograil™ announced today it has signed a Collaboration Agreement with CSL Behring Lengnau, a subsidiary of Australian biotech giant CSL. After obtaining successful early feasibility data, CSL and Biograil agreed to expand their collaboration. Under the agreement, CSL and Biograil will work together to advance BIONDD™, the Biograil drug delivery technology with respect to certain CSL proprietary compounds, seeking to achieve effective oral drug delivery of a compound which is injected today. The agreement includes upfront payments and research funding and an option to enter into an exclusive license incorporating a signing fee, development and commercial milestones, and royalties on product sales. Read the full press release: https://lnkd.in/duWHZwhx #pharmaceutical #pharma #biotech #biotechnology #startupnews #newcollaboration #health #healthnews